Zarqa’s Epilepsy Panel

“Unraveling the Complexity of Seizure Disorders”

Overview

Epilepsy encompasses a spectrum of seizure disorders, each presenting unique challenges in diagnosis and management. Zarqa’s Epilepsy Panel offers a comprehensive approach, targeting various seizure syndromes and associated genetic factors to provide accurate diagnoses and tailored treatment strategies.

Key Features:

Phenotype-Directed Testing

Our panel is designed to cover different types of seizure syndromes, including Dravet syndrome, early infantile epileptic encephalopathy, myoclonic epilepsy, and more.

Comprehensive Coverage

With 783 genes analyzed, including mitochondrial and nuclear mitochondrial genes, our panel ensures thorough examination of genetic factors contributing to epilepsy and related disorders.

Cutting-edge Technology

Utilizing Next-Generation Sequencing (NGS) with CNV analysis and repeat expansion analysis for precise and reliable results.

Fast Turnaround

Results delivered within 30 business days, enabling timely diagnosis and intervention for patients.

Common Syndromes Covered

Aicardi-Goutieres syndrome
Brain iron accumulation syndromes
Dravet syndrome
Early infantile epileptic encephalopathy
Epilepsy (absence) in childhood
Epilepsy (generalized) with febrile seizures
Epilepsy (partial)
Epileptic encephalopathy
Myoclonic epilepsy
Hypomagnesemia
Leigh syndrome
Mitochondrial encephalomyopathy
Muscular dystrophy-dystroglycanopathy
Urea cycle disorder

And more…

Sample Requirements:

Blood
Saliva
DBS
Tasso Kits

Coverage:

≥99.00% ≥20x

Unlock Precision with ZGL

Discover our advanced genomic testing services tailored for your specific needs. Contact us today to enhance your research with unparalleled accuracy and expertise.

Have any questions?